Yogurt for Prevention of Chronic Inflammation
Anti-inflammatory Activity of Yogurt Mediated by the Intestine
4 other identifiers
interventional
40
1 country
1
Brief Summary
The objective of this study is to conduct a randomized cross-over dietary intervention in adult women who are overweight or obese to compare how yogurt and a control food affect biomarkers of inflammation and intestinal health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable obesity
Started Oct 2021
Shorter than P25 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 29, 2019
CompletedFirst Posted
Study publicly available on registry
November 4, 2019
CompletedStudy Start
First participant enrolled
October 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2022
CompletedNovember 16, 2022
November 1, 2022
11 months
October 29, 2019
November 15, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Th17 proportion
Change in proportions of circulating Th17 cells (change in control vs. change in yogurt)
Baseline, Week 4, Week 8, Week 12
Secondary Outcomes (23)
Change in Treg proportion
Baseline, Week 4, Week 8, Week 12
Change in Treg subpopulation
Baseline, Week 4, Week 8, Week 12
Change in Th17 subpopulation (IL-17A+ TNFα+)
Baseline, Week 4, Week 8, Week 12
Change in Th17 subpopulation (IL-17A+ IFNδ+)
Baseline, Week 4, Week 8, Week 12
Change in Th17 subpopulation (IL-17A+ IL-22+)
Baseline, Week 4, Week 8, Week 12
- +18 more secondary outcomes
Other Outcomes (17)
Change in systolic blood pressure
Baseline, Week 4, Week 8, Week 12
Change in diastolic blood pressure
Baseline, Week 4, Week 8, Week 12
Change in BMI
Baseline, Week 4, Week 8, Week 12
- +14 more other outcomes
Study Arms (2)
Yogurt-Control
EXPERIMENTALConsumption of 12 oz. of low-fat yogurt daily (2 x 6 oz. servings) for 4 weeks, followed by a washout phase for 4 weeks, then consumption of 12 oz. control food (flavored soy pudding, 2 x 6 oz. servings) for 4 weeks.
Control-Yogurt
EXPERIMENTALConsumption of control food (flavored soy pudding, 2 x 6 oz. servings), followed by a washout phase for 4 weeks, then consumption of 12 oz. of low-fat yogurt daily (2 x 6 oz. servings) for 4 weeks.
Interventions
Eligibility Criteria
You may qualify if:
- healthy premenopausal women age 21-55
- BMI ≥ 25 kg/m2
- not taking medication to control hypertension (e.g. anti-hypertensives or diuretics)
- resting blood pressure \<140/90 mmHg
- stable body weight for past two months
- willing to maintain a normal exercise level (in general)
- willing to avoid exercise and smoking (or other forms of nicotine intake) for 24 h prior to blood collection
- willing to avoid caffeine for 12 h before study visits
- willing to fast 12 h prior to study visits
- willing to avoid dietary supplements, yogurt and probiotic-containing foods (as necessary) and consume 12 oz. of yogurt and the control food per day (as necessary) for the duration of the study
You may not qualify if:
- self-reported previous diagnoses of an inflammatory disease (e.g. inflammatory bowel disease, asthma, arthritis), CVD, diabetes, current cancer treatment (i.e., chemotherapy, radiation therapy)
- have used oral antibiotics in the prior 21 days before sample collection
- actively trying to lose weight
- regularly taking anti-inflammatory drugs
- vegetarian or allergic to soy or dairy
- are pregnant, lactating, or trying to become pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Wisconsin, Madisonlead
- National Dairy Councilcollaborator
- University of Massachusetts, Amherstcollaborator
Study Sites (1)
Department of Food Science, Babcock Hall
Madison, Wisconsin, 53706, United States
Related Publications (1)
Hasegawa Y, Noll AL, Lang DJ, Akfaly EM, Liu Z, Bolling BW. Low-fat yogurt consumption maintains biomarkers of immune function relative to nondairy control food in women with elevated BMI: A randomized controlled crossover trial. Nutr Res. 2024 Sep;129:1-13. doi: 10.1016/j.nutres.2024.07.005. Epub 2024 Jul 24.
PMID: 39153426DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bradley W Bolling, PhD
University of Wisconsin, Madison
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 29, 2019
First Posted
November 4, 2019
Study Start
October 15, 2021
Primary Completion
September 1, 2022
Study Completion
September 1, 2022
Last Updated
November 16, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share